SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Corey S. Davis, Traci C. Green, Nickolas D. Zaller, Addressing the overdose epidemic requires timely access to data to guide interventions, Drug and Alcohol Review, 2016, 35, 1
  2. 2
    Wayne Wakeland, Alexandra Nielsen, Teresa D. Schmidt, Gaining Policy Insight with a System Dynamics Model of Pain Medicine Prescribing, Diversion and Abuse, Systems Research and Behavioral Science, 2016, 33, 1
  3. 3
    Sameer Hassamal, Lori Keyser-Marcus, Ericka Crouse Breden, Kathrin Hobron, Atit Bhattachan, Ananda Pandurangi, A Brief Analysis of Suicide Methods and Trends in Virginia from 2003 to 2012, BioMed Research International, 2015, 2015, 1

    CrossRef

  4. 4
    Chris Delcher, Alexander C. Wagenaar, Bruce A. Goldberger, Robert L. Cook, Mildred M. Maldonado-Molina, Abrupt decline in oxycodone-caused mortality after implementation of Florida's Prescription Drug Monitoring Program, Drug and Alcohol Dependence, 2015, 150, 63

    CrossRef

  5. 5
    Margaret B. Greenwood-Ericksen, Sabrina J. Poon, Lewis S. Nelson, Scott G. Weiner, Jeremiah D. Schuur, Best Practices for Prescription Drug Monitoring Programs in the Emergency Department Setting: Results of an Expert Panel, Annals of Emergency Medicine, 2015,

    CrossRef

  6. 6
    Frederick Fiesseler, Renee Riggs, David Salo, Richard Klemm, Ashley Flannery, Richard Shih, Care plans reduce ED visits in those with drug-seeking behavior, The American Journal of Emergency Medicine, 2015, 33, 12, 1799

    CrossRef

  7. 7
    Benedikt Fischer, Chantal Burnett, Jürgen Rehm, Considerations towards a population health approach to reduce prescription opioid-related harms (with a primary focus on Canada), Drugs: Education, Prevention and Policy, 2015, 22, 1, 60

    CrossRef

  8. 8
    Leonard J. Paulozzi, Gail K. Strickler, Peter W. Kreiner, Caitlin M. Koris, Controlled Substance Prescribing Patterns — Prescription Behavior Surveillance System, Eight States, 2013, MMWR. Surveillance Summaries, 2015, 64, No. SS-9, 1

    CrossRef

  9. 9
    Gerald Cochran, Bongki Woo, Wei-Hsuan Lo-Ciganic, Adam J. Gordon, Julie M. Donohue, Walid F. Gellad, Defining Nonmedical Use of Prescription Opioids Within Health Care Claims: A Systematic Review, Substance Abuse, 2015, 36, 2, 192

    CrossRef

  10. 10
    Traci C. Green, Sarah Bowman, Corey Davis, Cristina Los, Kimberly McHugh, Peter D. Friedmann, Discrepancies in addressing overdose prevention through prescription monitoring programs, Drug and Alcohol Dependence, 2015, 153, 355

    CrossRef

  11. 11
    Joanne E. Brady, Charles J. DiMaggio, Katherine M. Keyes, John J. Doyle, Lynne D. Richardson, Guohua Li, Emergency department utilization and subsequent prescription drug overdose death, Annals of Epidemiology, 2015, 25, 8, 613

    CrossRef

  12. 12
    Lisham Ashrafioun, Amy S.B. Bohnert, Mary Jannausch, Mark A. Ilgen, Evaluation of the Current Opioid Misuse Measure Among Substance Use Disorder Treatment Patients, Journal of Substance Abuse Treatment, 2015, 55, 15

    CrossRef

  13. 13
    Samantha A. Hollingworth, Paul D. Gray, Wayne D. Hall, Jake M. Najman, Opioid analgesic prescribing in Australia: a focus on gender and age, Pharmacoepidemiology and Drug Safety, 2015, 24, 6
  14. 14
    Sherry L. Green, Stacey Pfenning, Optimizing the Use of State Prescription Drug Monitoring Programs for Public Safety, Journal of Nursing Regulation, 2015, 6, 3, 4

    CrossRef

  15. 15
    Brandon C. Maughan, Marcus A. Bachhuber, Nandita Mitra, Joanna L. Starrels, Prescription monitoring programs and emergency department visits involving opioids, 2004–2011, Drug and Alcohol Dependence, 2015, 156, 282

    CrossRef

  16. 16
    Declan T. Barry, Mehmet Sofuoglu, Robert D. Kerns, Ilse R. Wiechers, Robert A. Rosenheck, Prevalence and correlates of co-prescribing psychotropic medications with long-term opioid use nationally in the Veterans Health Administration, Psychiatry Research, 2015, 227, 2-3, 324

    CrossRef

  17. 17
    Mei-Sing Ong, Karen L. Olson, Aurel Cami, Chunfu Liu, Fang Tian, Nandini Selvam, Kenneth D. Mandl, Provider Patient-Sharing Networks and Multiple-Provider Prescribing of Benzodiazepines, Journal of General Internal Medicine, 2015,

    CrossRef

  18. 18
    Chris Ringwalt, Mariana Garrettson, Apostolos Alexandridis, The Effects of North Carolina’s Prescription Drug Monitoring Program on the Prescribing Behaviors of the State’s Providers, The Journal of Primary Prevention, 2015, 36, 2, 131

    CrossRef

  19. 19
    Andrew B. Kanouse, Peggy Compton, The Epidemic of Prescription Opioid Abuse, the Subsequent Rising Prevalence of Heroin Use, and the Federal Response, Journal of Pain & Palliative Care Pharmacotherapy, 2015, 29, 2, 102

    CrossRef

  20. 20
    Christopher Ringwalt, Sharon Schiro, Meghan Shanahan, Scott Proescholdbell, Harold Meder, Anna Austin, Nidhi Sachdeva, The Use of a Prescription Drug Monitoring Program to Develop Algorithms to Identify Providers With Unusual Prescribing Practices for Controlled Substances, The Journal of Primary Prevention, 2015, 36, 5, 287

    CrossRef

  21. 21
    Benedikt Fischer, Annette Keates, Gerhard Bühringer, Jens Reimer, Jürgen Rehm, Considering prescription opioid-related harms in the population: Response to commentaries, Addiction, 2014, 109, 2
  22. 22
    Nicholas B. King, Veronique Fraser, Constantina Boikos, Robin Richardson, Sam Harper, Determinants of Increased Opioid-Related Mortality in the United States and Canada, 1990–2013: A Systematic Review, American Journal of Public Health, 2014, 104, 8, e32

    CrossRef

  23. 23
    Louis Alexander, Richard O. Mannion, Brianne Weingarten, Richard J. Fanelli, Gary L. Stiles, Development and impact of prescription opioid abuse deterrent formulation technologies, Drug and Alcohol Dependence, 2014, 138, 1

    CrossRef

  24. 24
    Michael E. Nelson, Sean M. Bryant, Steven E. Aks, Emerging drugs of abuse, Disease-a-Month, 2014, 60, 3, 110

    CrossRef

  25. 25
    Michael E. Nelson, Sean M. Bryant, Steven E. Aks, Emerging Drugs of Abuse, Emergency Medicine Clinics of North America, 2014, 32, 1, 1

    CrossRef

  26. 26
    Kohei Hasegawa, David F.M. Brown, Yusuke Tsugawa, Carlos A. Camargo, Epidemiology of Emergency Department Visits for Opioid Overdose: A Population-Based Study, Mayo Clinic Proceedings, 2014, 89, 4, 462

    CrossRef

  27. 27
    Corey S. Davis, Matthew Pierce, Nabarun Dasgupta, Evolution and Convergence of State Laws Governing Controlled Substance Prescription Monitoring Programs, 1998-2011, American Journal of Public Health, 2014, 104, 8, 1389

    CrossRef

  28. 28
    Paul Gavaza, Marc Fleming, Jamie C. Barner, Examination of psychosocial predictors of Virginia pharmacists' intention to utilize a prescription drug monitoring program using the theory of planned behavior, Research in Social and Administrative Pharmacy, 2014, 10, 2, 448

    CrossRef

  29. 29
    Richard A. Deyo, Jessica M. Irvine, Sara E. Hallvik, Christi Hildebran, Todd Beran, Lisa M. Millet, Miguel Marino, Leading a Horse to Water, The Clinical Journal of Pain, 2014, 1

    CrossRef

  30. 30
    T. J. Brophy, H. A. Spiller, M. J. Casavant, T. Chounthirath, M. D. Smith, H. Xiang, Medication errors reported to U.S. Poison Control Centers, 2000–2012, Clinical Toxicology, 2014, 52, 8, 880

    CrossRef

  31. 31
    Inna Gridchyna, Anne-Marie Cloutier, Lenhangmbong Nkeng, Camille Craig, Sarah Frise, Yola Moride, Methodological gaps in the assessment of risk minimization interventions: a systematic review, Pharmacoepidemiology and Drug Safety, 2014, 23, 6
  32. 32
    Karon F Cook, Chester Buckenmaier, Richard C Gershon, PASTOR/PROMIS®pain outcomes system: what does it mean to pain specialists?, Pain Management, 2014, 4, 4, 277

    CrossRef

  33. 33
    Michael Hoefer, Ismene Petrakis, Prescription drug monitoring programs and buprenorphine maintenance: Clinical considerations, The American Journal on Addictions, 2014, 23, 6
  34. 34
    Daniel F. Weisberg, William C. Becker, David A. Fiellin, Cathy Stannard, Prescription opioid misuse in the United States and the United Kingdom: Cautionary lessons, International Journal of Drug Policy, 2014, 25, 6, 1124

    CrossRef

  35. 35
    Nelson E. Sessler, Jerod M. Downing, Hrishikesh Kale, Howard D. Chilcoat, Todd F. Baumgartner, Paul M. Coplan, Reductions in reported deaths following the introduction of extended-release oxycodone (OxyContin) with an abuse-deterrent formulation, Pharmacoepidemiology and Drug Safety, 2014, 23, 12
  36. 36
    Benedikt Fischer, Wayne Jones, Jürgen Rehm, Trends and changes in prescription opioid analgesic dispensing in Canada 2005–2012: an update with a focus on recent interventions, BMC Health Services Research, 2014, 14, 1, 90

    CrossRef

  37. 37
    Kohei Hasegawa, Janice A. Espinola, David F. M. Brown, Carlos A. Camargo, Trends in U.S. Emergency Department Visits for Opioid Overdose, 1993–2010, Pain Medicine, 2014, 15, 10
  38. 38
    Tamara M. Haegerich, Leonard J. Paulozzi, Brian J. Manns, Christopher M. Jones, What we know, and don’t know, about the impact of state policy and systems-level interventions on prescription drug overdose, Drug and Alcohol Dependence, 2014, 145, 34

    CrossRef

  39. 39
    Roger Nicholas, Ann Roche, Malcolm Dobbin, Nicole Lee, Beyond the paper trail: using technology to reduce escalating harms from opioid prescribing in Australia, Australian and New Zealand Journal of Public Health, 2013, 37, 2
  40. 40
    Paul M. Coplan, Hrishikesh Kale, Lauren Sandstrom, Craig Landau, Howard D. Chilcoat, Changes in oxycodone and heroin exposures in the National Poison Data System after introduction of extended-release oxycodone with abuse-deterrent characteristics, Pharmacoepidemiology and Drug Safety, 2013, 22, 12
  41. 41
    Brian D. Johnston, Beth E. Ebel, Child Injury Control: Trends, Themes, and Controversies, Academic Pediatrics, 2013, 13, 6, 499

    CrossRef

  42. 42
    Todd J. Stanhope, Lisa A. Gill, Carl Rose, Chronic Opioid Use During Pregnancy, Clinics in Perinatology, 2013, 40, 3, 337

    CrossRef

  43. 43
    Jacob T. Painter, Leslie J. Crofford, Jeffery Talbert, Geographic Variation of Chronic Opioid Use in Fibromyalgia, Clinical Therapeutics, 2013, 35, 3, 303

    CrossRef

  44. 44
    Benedikt Fischer, Wayne Jones, Jürgen Rehm, High correlations between levels of consumption and mortality related to strong prescription opioid analgesics in British Columbia and Ontario, 2005 – 2009, Pharmacoepidemiology and Drug Safety, 2013, 22, 4
  45. 45
    Laxmaiah Manchikanti, Mark V Boswell, Joshua A Hirsch, Lessons learned in the abuse of pain-relief medication: a focus on healthcare costs, Expert Review of Neurotherapeutics, 2013, 13, 5, 527

    CrossRef

  46. You have free access to this content46
    D. Weisberg, C. Stannard, Lost in translation? Learning from the opioid epidemic in the USA, Anaesthesia, 2013, 68, 12
  47. 47
    Alex S. Bennett, Luther Elliott, Andrew Golub, Opioid and Other Substance Misuse, Overdose Risk, and the Potential for Prevention Among a Sample of OEF/OIF Veterans in New York City, Substance Use & Misuse, 2013, 48, 10, 894

    CrossRef

  48. 48
    J. Cameron Muir, Carl Scheffey, Heidi M. Young, Agustin O. Vilches, Malene S. Davis, Stephen R. Connor, Opioid Prescribing Practices Before and After Initiation of Palliative Care in Outpatients, Journal of Pain and Symptom Management, 2013, 45, 6, 1107

    CrossRef

  49. 49
    Gerald Cochran, Craig Field, Kenneth Lawson, Carlton Erickson, Pharmacists' knowledge, attitudes and beliefs regarding screening and brief intervention for prescription opioid abuse: a survey of Utah and Texas pharmacists, Journal of Pharmaceutical Health Services Research, 2013, 4, 2
  50. 50
    Karen H. Wang, William C. Becker, David A. Fiellin, Prevalence and correlates for nonmedical use of prescription opioids among urban and rural residents, Drug and Alcohol Dependence, 2013, 127, 1-3, 156

    CrossRef

  51. 51
    Darius A. Rastegar, Alexander Y. Walley, Preventing Prescription Opioid Overdose Deaths, Journal of General Internal Medicine, 2013, 28, 10, 1258

    CrossRef

  52. 52
    F. Modarai, K. Mack, P. Hicks, S. Benoit, S. Park, C. Jones, S. Proescholdbell, A. Ising, L. Paulozzi, Relationship of opioid prescription sales and overdoses, North Carolina, Drug and Alcohol Dependence, 2013, 132, 1-2, 81

    CrossRef

  53. 53
    Laura Morgan, Michael Weaver, Zabe Sayeed, Ralph Orr, The Use of Prescription Monitoring Programs to Reduce Opioid Diversion and Improve Patient Safety, Journal of Pain and Palliative Care Pharmacotherapy, 2013, 27, 1, 4

    CrossRef

  54. 54
    Amy S. B. Bohnert, Mark A. Ilgen, Jodie A. Trafton, Robert D. Kerns, Anna Eisenberg, Dara Ganoczy, Frederic C. Blow, Trends and Regional Variation in Opioid Overdose Mortality Among Veterans Health Administration Patients, Fiscal Year 2001 to 2009, The Clinical Journal of Pain, 2013, 1

    CrossRef

  55. 55
    Erin M. Johnson, William A. Lanier, Ray M. Merrill, Jacob Crook, Christina A. Porucznik, Robert T. Rolfs, Brian Sauer, Unintentional Prescription Opioid-Related Overdose Deaths: Description of Decedents by Next of Kin or Best Contact, Utah, 2008–2009, Journal of General Internal Medicine, 2013, 28, 4, 522

    CrossRef

  56. 56
    Stephen V. Cantrill, Michael D. Brown, Russell J. Carlisle, Kathleen A. Delaney, Daniel P. Hays, Lewis S. Nelson, Robert E. O'Connor, AnnMarie Papa, Karl A. Sporer, Knox H. Todd, Rhonda R. Whitson, Clinical Policy: Critical Issues in the Prescribing of Opioids for Adult Patients in the Emergency Department, Annals of Emergency Medicine, 2012, 60, 4, 499

    CrossRef

  57. 57
    MALCOLM D. DOBBIN, MICHAEL A. MCDONOUGH, Commentary on Kurdyak et al. (2012): Methadone and other opioids – need for coordinated prescribing, Addiction, 2012, 107, 4
  58. 58
    Liza M. Reifler, Danna Droz, J. Elise Bailey, Sidney H. Schnoll, Reginald Fant, Richard C. Dart, Becki Bucher Bartelson, Do Prescription Monitoring Programs Impact State Trends in Opioid Abuse/Misuse?, Pain Medicine, 2012, 13, 3
  59. 59
    Traci C. Green, Marita R. Mann, Sarah E. Bowman, Nickolas Zaller, Xaviel Soto, John Gadea, Catherine Cordy, Patrick Kelly, Peter D. Friedmann, How Does Use of a Prescription Monitoring Program Change Medical Practice?, Pain Medicine, 2012, 13, 10
  60. 60
    Linda Simoni-Wastila, Jingjing Qian, Influence of prescription monitoring programs on analgesic utilization by an insured retiree population, Pharmacoepidemiology and Drug Safety, 2012, 21, 12
  61. 61
    Lance Feldman, Kristi Skeel Williams, Michele Knox, John Coates, Influencing Controlled Substance Prescribing: Attending and Resident Physician Use of a State Prescription Monitoring Program, Pain Medicine, 2012, 13, 7
  62. 62
    Jeanmarie Perrone, Francis J. DeRoos, Lewis S. Nelson, Prescribing Practices, Knowledge, and Use of Prescription Drug Monitoring Programs (PDMP) by a National Sample of Medical Toxicologists, 2012, Journal of Medical Toxicology, 2012, 8, 4, 341

    CrossRef

  63. 63
    Julie Worley, Prescription Drug Monitoring Programs, a Response to Doctor Shopping: Purpose, Effectiveness, and Directions for Future Research, Issues in Mental Health Nursing, 2012, 33, 5, 319

    CrossRef

  64. 64
    PATRICIA ANNE O’MALLEY, Prescription Opioid Abuse Update for the Clinical Nurse Specialist, Clinical Nurse Specialist, 2012, 26, 1, 19

    CrossRef

  65. 65
    Mathias B. Forrester, Temporal and Geographic Patterns in Opioid Abuse in Texas, Journal of Addictive Diseases, 2012, 31, 2, 93

    CrossRef

  66. 66
    Hallam Gugelmann, Jeanmarie Perrone, Lewis Nelson, Windmills and Pill Mills: Can PDMPs Tilt the Prescription Drug Epidemic?, Journal of Medical Toxicology, 2012, 8, 4, 378

    CrossRef

  67. 67
    SCOTT M. FISHMAN, Prescription Drug Monitoring Programs Serve a Vital Clinical Need, Pain Medicine, 2011, 12, 6
  68. 68
    GIL KERLIKOWSKE, CHRISTOPHER M. JONES, REGINA M. LABELLE, TIMOTHY P. CONDON, Prescription Drug Monitoring Programs—Lack of Effectiveness or a Call to Action?, Pain Medicine, 2011, 12, 5